TEVA - Teva Pharmaceut Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 UGAZ (3.43%) TVIX (-7.28%) TPR (0.88%) SPY (1.1%) SMH (1.95%) RETA (55.18%) ONCS (-1.95%) OKTA (0.1%) NVDA (5.32%) NTRP (0.57%) LULU (0.34%) JPM (3.33%) IWM (1.07%) ICLN (-1.14%) HPQ (1.15%) GSKY (4.19%) GS (0.55%) GOGO (1.29%) FUNC (-0.48%) FDX (2.15%) ESNT (2.67%) DVN (-0.39%) DLR (-0.39%) DGAZ (-3.19%) BBBY (-2.65%)

TEVA - Teva Pharmaceutical ...

$6.99 0.26[%]

15 mins delayed data

People also watch :

+Watchlist

18 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$6.73	Open	$6.70
Volume	11.08M	Market Cap	9.657B
Yield		Last Dividend

Day

52 Week

J&J (JNJ) Beats on Q3 Earnings as Sales ...	8:42 AM
J&J (JNJ) comes up with encouraging third-quarter 2019 results.

Lilly Gets FDA Approval for New Oral Tab...	10/14/19
Eli Lilly (LLY) gets FDA approval for lasmiditan oral tablets to treat acute migraine in adults.

Lifshitz & Miller LLP Announces Investig...	10/13/19
NEW YORK , Oct. 13, 2019 /PRNewswire/ -- Allegiant Travel Company (ALGT) Lifshitz & Miller announces investigation into possible securities laws in co...

Emergent's Vaccine Profile Boosts Sa...	10/08/19
Emergent's (EBS) vaccine portfolio holds great potential with the newly-acquired Narcan nasal spray progressing well. Severe rivalry remains a con...

Teva Pharmaceutical Industries Ltd. (TEV...	10/07/19
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.

Teva to Host Conference Call to Discuss ...	10/07/19
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its third quarter 2019 financial resul...

AstraZeneca's Fasenra Gets FDA Nod f...	10/07/19
The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO ...

Bausch Files Lawsuit Against Novartis...	10/03/19
Bausch's (BHC) shares down on lawsuit filed against Novartis' Sandoz defending Xifaxan patents.

The Market Tells Opioid Drugmakers to Se...	10/02/19
(Bloomberg Opinion) -- The markets are sending a message to drugmakers facing opioid litigation: Settle up.Johnson & Johnson late Tuesday announced it...

JNJ moves to dodge opioid bullets, but o...	10/02/19
Opioid litigation increasingly affecting credit outlooks for drug makers and distributors.

Teva to Present New Data on AUSTEDO® (de...	10/02/19
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO® (deutetrabenazine) data will be presented at the 32nd annu...

ANALYST RATINGS

9 analyst ratings (Last 6 months)

44.44 %

Strong Buy + Buy

Price Target (PT)

Buy rating	09/30/19
Wells Fargo maintains Market Perform rating and lowers Price Target from $17.00 to $8.00

Sell rating	09/06/19
JP Morgan maintains Underweight rating and lowers Price Target from $9.00 to $7.00

Buy rating	08/09/19
BMO Capital maintains Market Perform rating and lowers Price Target from $11.00 to $9.00

Sell rating	07/15/19
Morgan Stanley downgrades from Equal-Weight to Underweight rating and lowers Price Target from $16.00 to $6.00

Sell rating	06/11/19
Barclays initiates coverage with Underweight rating and announces Price Target of $8.00

Strong Buy rating	06/03/19
Oppenheimer upgrades from Perform to Outperform rating and announces Price Target of $12.00

Underperform rating	05/30/19
Bank of America downgrades from Buy to Underperform rating and lowers Price Target from $19.00 to $9.00

Hold rating	05/28/19
UBS downgrades from Buy to Neutral rating and lowers Price Target from $22.00 to $12.00

Buy rating	05/09/19
Wells Fargo maintains Market Perform rating and lowers Price Target from $18.00 to $17.00

EARNINGS

Date	2019-08-07 (BMO)	Est. (EPS/Rev.)	$0.57/ 4.25B
Actual (EPS/Rev.)	$0.60/ $4.34 B	EPS (TTM)	0

TRADERS TRACKING $TEVA

Service Name	Trader	% Success
Equity and Teens	Equity and Teens	100.00 %	Follow
Trading	Trading	99.00 %	Follow
Swing for the fences	Gino Baldassano	76.00 %	Follow
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
smashingdon	Paul	70.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.